Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Science Press Releases.
Press releases published on June 11, 2025

OSS’s BRESSNER Receives the 2024 EMEA Growth Partner of the Year Award from Digi International
ESCONDIDO, Calif., June 11, 2025 (GLOBE NEWSWIRE) -- One Stop Systems, Inc. (OSS or the Company) (Nasdaq: OSS) today announced that its subsidiary, BRESSNER Technology GmbH, a leading specialized high-performance computing supplier in Europe, has been …

Tempest Announces $4.6 Million Registered Direct Offering of Common Stock
BRISBANE, Calif., June 11, 2025 (GLOBE NEWSWIRE) -- Tempest Therapeutics, Inc. (Nasdaq: TPST), a clinical-stage biotechnology company with a pipeline of first-in-class1 targeted and immune-mediated therapeutics to fight cancer, today announced that it has …

Radiopharm Theranostics Granted U.S. Food and Drug Administration Fast Track Designation for RAD101 Imaging in Brain Metastases
SYDNEY, June 11, 2025 (GLOBE NEWSWIRE) -- Radiopharm Theranostics (ASX:RAD, “Radiopharm” or the “Company”), a clinical-stage biopharmaceutical company focused on developing innovative oncology radiopharmaceuticals for areas of high unmet medical need, …

RTI Connext Receives Industry Recognition as Leading Data Platform for Autonomous Systems
SUNNYVALE, Calif., June 11, 2025 (GLOBE NEWSWIRE) -- Real-Time Innovations (RTI), the software framework company for physical AI systems, today announced that RTI Connext® has been selected as the winner of the Top Unmanned Systems Data Processing and …

Kratos Awarded $25 Million Task Order for U.S. Space Force’s Evolved Strategic SATCOM
SAN DIEGO, June 11, 2025 (GLOBE NEWSWIRE) -- Kratos Defense …

vTv Therapeutics to Participate in the H.C. Wainwright “HCW@Home” Series
HIGH POINT, N.C., June 11, 2025 (GLOBE NEWSWIRE) -- vTv Therapeutics Inc. (Nasdaq: VTVT), a clinical stage biopharmaceutical company focused on the development of cadisegliatin, a potential first-in-class oral adjunctive therapy to insulin being …

House of Doge Appoints Fintech Leaders as CEO and Chief Payments Officer to Lead Global Expansion into Payments
MIAMI, June 11, 2025 (GLOBE NEWSWIRE) -- House of Doge, the official corporate arm of the Dogecoin Foundation, today announced the appointment of Marco Margiotta as Chief Executive Officer and Ryan Deslippe as Chief Payments Officer. The two fintech …

Legal Claim Assistant Shares Research Insights on Prenatal PFAS Exposure and Child Health
Scientific agencies report associations between prenatal PFAS exposure and child health indicators—Legal Claim Assistant offers public information. MIAMI, FLORIDA, FL, UNITED STATES, June 10, 2025 /EINPresswire.com/ -- Legal Claim Assistant is …

Pacira BioSciences Unveils Three-Year Clinical Data Following a Single Local Administration of Investigational Gene Therapy, PCRX-201, in Patients with Moderate-to-Severe Osteoarthritis of the Knee
-- PCRX-201 demonstrated sustained clinical efficacy with improvements in pain, stiffness, and function for up to three years – BRISBANE, Calif., June 11, 2025 (GLOBE NEWSWIRE) -- Pacira BioSciences, Inc. (NASDAQ: PCRX), the industry leader in the delivery …

ImmuneWalk Therapeutics Announces Positive Topline Phase 1 SAD Data for Immunology and Inflammation Drug Candidate IW-601
Study met primary endpoint of safety and tolerability at all doses and secondary pharmacodynamic and pharmacokinetic endpoints after single subcutaneous administration Pharmacodynamics provides mechanistic validation, demonstrating dose-dependent binding …

Florida Oncology and Hematology Moves Naples-Goodlette Clinic to Larger Location
NAPLES, Fla., June 11, 2025 (GLOBE NEWSWIRE) -- Florida Oncology and Hematology, a partner practice of American Oncology Network (AON), has relocated its Goodlette clinic in Naples to 708 Goodlette-Frank Road, Suite 302, 3rd Floor. Current or prospective …

Adial Pharmaceuticals Advances Toward Phase 3 Development for AD04
GLEN ALLEN, Va., June 11, 2025 (GLOBE NEWSWIRE) -- Adial Pharmaceuticals, Inc. (NASDAQ: ADIL) (“Adial” or the “Company”), a clinical-stage biopharmaceutical company focused on developing precision treatments for addiction and related disorders, today …

Vivani Medical Appoints Anthony Baldor as Chief Financial Officer
ALAMEDA, Calif., June 11, 2025 (GLOBE NEWSWIRE) -- Vivani Medical, Inc. (NASDAQ: VANI) (“Vivani” or the “Company”), a clinical-stage biopharmaceutical company developing miniature, ultra long-acting drug implants, today announced the appointment of Anthony …

Chiesi Group Enters into Worldwide Licensing Agreement with Key2Brain AB to Advance Blood-Brain Barrier-Crossing Therapies for Lysosomal Storage Disorders
Collaboration will leverage Key2Brain’s technology to develop blood-brain barrier-crossing enzyme replacement therapies for lysosomal storage disorders Agreement is built on a partnership initiated in 2022, supporting continued development led by positive …

Chemomab Reports Positive Feedback From Two Recent FDA Meetings Supporting Phase 3 Advancement of Nebokitug in Primary Sclerosing Cholangitis
—Achieves FDA Alignment on CMC and Non-Clinical Toxicology Regulatory Path for Nebokitug in PSC— —Preparations for the Nebokitug PSC Phase 3 Clinical Trial Advance as Discussions with Potential Strategic Partners Continue— TEL AVIV, Israel, June 11, 2025 ( …

Repeat: Treatment.com AI Announces New Medical Education Suite to Enhance Clinical Skills Training Through AI-Simulated Patients
Updated AI-powered OSCE platform launched to enhance medical education delivery and evaluation. Successfully deployed at University of Minnesota with 240 students and potential of ~40% cost savings. Features AI-simulated patients and real-time scoring to …

BigCommerce Earns 2025 Top Rated Award from TrustRadius
AUSTIN, Texas, June 11, 2025 (GLOBE NEWSWIRE) -- BigCommerce (Nasdaq: BIGC), a leading provider of open, composable commerce solutions for B2C and B2B brands, retailers, manufacturers and distributors, today announced that TrustRadius has recognized …

List Of Technologically Progressive Featured Winners Represent Excellence In 2025 SupplyTech Breakthrough Awards Program
LOS ANGELES, June 11, 2025 (GLOBE NEWSWIRE) -- SupplyTech Breakthrough, a leading independent market intelligence organization that evaluates and recognizes standout technology companies, products and services in the supply chain technology and logistics …

Cogent Biosciences Secures up to $400 Million in Non-Dilutive Financing
Facility provides additional funding for next steps of the Company’s growth, including the expected launch of bezuclastinib in 2026 On track to report results from three pivotal trials this year, beginning with SUMMIT results in July WALTHAM, Mass. and …

uniQure Announces Appointment of Kylie O’Keefe as Chief Customer and Strategy Officer
~ Proven biotech executive to lead commercialization of AMT-130 in Huntington’s disease ~ LEXINGTON, Mass. and AMSTERDAM, June 11, 2025 (GLOBE NEWSWIRE) -- uniQure N.V. (NASDAQ: QURE), a leading gene therapy company advancing transformative therapies for …